Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Feldman

Showing results (1051-1060 of 1,068) with videos related to

Pageof 107
Sort By:
MMWR. Morbidity and Mortality Weekly Report|March 7, 2014
Notes from the field: rapidly growing nontuberculous Mycobacterium wound infections among medical tourists undergoing cosmetic surgeries in the Dominican Republic--multiple states, March 2013-February 2014David Schnabel, Joanna Gaines, Duc B Nguyen, et al.
Nature Medicine|September 13, 2022
Post-infusion CAR T<sub>Reg</sub> cells identify patients resistant to CD19-CAR therapyZinaida Good, Jay Y Spiegel, Bita Sahaf, et al.
Journal of Clinical and Translational Science|December 2, 2024
Assessments of working group effectiveness in the planning of the New Jersey Kids Study: An applied mixed-methods study on the science of team scienceRalph A Gigliotti, Melissa Weidner, Michelle Jansen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 5, 2013
Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapyRichard A Morgan, Nachimuthu Chinnasamy, Daniel Abate-Daga, et al.
Blood|January 29, 2021
CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphomaJohn H Baird, Matthew J Frank, Juliana Craig, et al.
Blood Advances|August 14, 2025
Camidanlumab Tesirine for Relapsed or Refractory Classic Hodgkin Lymphoma: A Phase 2 StudyAlex F Herrera, Stephen M Ansell, Pier Luigi Zinzani, et al.
Leukemia|March 16, 2024
CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b resultsLiora M Schultz, Nikeshan Jeyakumar, Anne Marijn Kramer, et al.
Developmental Cell|April 29, 2023
Transcription factor induction of vascular blood stem cell niches in vivoElliott J Hagedorn, Julie R Perlin, Rebecca J Freeman, et al.
Immunity|March 10, 2021
Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discoveryShin-Heng Chiou, Diane Tseng, Alexandre Reuben, et al.
Nature|February 7, 2022
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomasRobbie G Majzner, Sneha Ramakrishna, Kristen W Yeom, et al.
Pageof 107

Showing results (1051-1060 of 1,068) with videos related to

Sort By:
Pageof 107
MMWR. Morbidity and Mortality Weekly Report|March 7, 2014
Notes from the field: rapidly growing nontuberculous Mycobacterium wound infections among medical tourists undergoing cosmetic surgeries in the Dominican Republic--multiple states, March 2013-February 2014David Schnabel, Joanna Gaines, Duc B Nguyen, et al.
Nature Medicine|September 13, 2022
Post-infusion CAR T<sub>Reg</sub> cells identify patients resistant to CD19-CAR therapyZinaida Good, Jay Y Spiegel, Bita Sahaf, et al.
Journal of Clinical and Translational Science|December 2, 2024
Assessments of working group effectiveness in the planning of the New Jersey Kids Study: An applied mixed-methods study on the science of team scienceRalph A Gigliotti, Melissa Weidner, Michelle Jansen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 5, 2013
Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapyRichard A Morgan, Nachimuthu Chinnasamy, Daniel Abate-Daga, et al.
Blood|January 29, 2021
CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphomaJohn H Baird, Matthew J Frank, Juliana Craig, et al.
Blood Advances|August 14, 2025
Camidanlumab Tesirine for Relapsed or Refractory Classic Hodgkin Lymphoma: A Phase 2 StudyAlex F Herrera, Stephen M Ansell, Pier Luigi Zinzani, et al.
Leukemia|March 16, 2024
CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b resultsLiora M Schultz, Nikeshan Jeyakumar, Anne Marijn Kramer, et al.
Developmental Cell|April 29, 2023
Transcription factor induction of vascular blood stem cell niches in vivoElliott J Hagedorn, Julie R Perlin, Rebecca J Freeman, et al.
Immunity|March 10, 2021
Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discoveryShin-Heng Chiou, Diane Tseng, Alexandre Reuben, et al.
Nature|February 7, 2022
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomasRobbie G Majzner, Sneha Ramakrishna, Kristen W Yeom, et al.
Pageof 107